Follow
Xinyu R. Ma
Xinyu R. Ma
Verified email at tamu.edu
Title
Cited by
Cited by
Year
A quick route to multiple highly potent SARS‐CoV‐2 main protease inhibitors
KS Yang, XR Ma, Y Ma, YR Alugubelli, DA Scott, EC Vatansever, ...
ChemMedChem 16 (6), 942-948, 2021
1032021
MPI8 is potent against SARS‐CoV‐2 by inhibiting dually and selectively the SARS‐CoV‐2 main protease and the host cathepsin L
XR Ma, YR Alugubelli, Y Ma, EC Vatansever, DA Scott, Y Qiao, G Yu, ...
ChemMedChem 17 (1), e202100456, 2022
612022
Evaluation of SARS-CoV-2 main protease inhibitors using a novel cell-based assay
W Cao, CCD Cho, ZZ Geng, N Shaabani, XR Ma, EC Vatansever, ...
ACS central science 8 (2), 192-204, 2022
352022
A multi-pronged evaluation of aldehyde-based tripeptidyl main protease inhibitors as SARS-CoV-2 antivirals
Y Ma, KS Yang, ZZ Geng, YR Alugubelli, N Shaabani, EC Vatansever, ...
European Journal of Medicinal Chemistry 240, 114570, 2022
312022
A systematic exploration of boceprevir-based main protease inhibitors as SARS-CoV-2 antivirals
YR Alugubelli, ZZ Geng, KS Yang, N Shaabani, K Khatua, XR Ma, ...
European Journal of Medicinal Chemistry 240, 114596, 2022
262022
Discovery of selective small-molecule inhibitors for the ENL YEATS domain
XR Ma, L Xu, S Xu, BJ Klein, H Wang, S Das, K Li, KS Yang, S Sohail, ...
Journal of medicinal chemistry 64 (15), 10997-11013, 2021
232021
The pyrrolysyl-tRNA synthetase activity can be improved by a P188 mutation that stabilizes the full-length enzyme
CC Cho, LR Blankenship, X Ma, S Xu, W Liu
Journal of molecular biology 434 (8), 167453, 2022
112022
A systematic survey of reversibly covalent dipeptidyl inhibitors of the SARS-CoV-2 main protease
ZZ Geng, S Atla, N Shaabani, V Vulupala, KS Yang, YR Alugubelli, ...
Journal of Medicinal Chemistry 66 (16), 11040-11055, 2023
82023
Cellular activities of SARS-CoV-2 main protease inhibitors reveal their unique characteristics
W Cao, CCD Cho, ZZ Geng, XR Ma, R Allen, N Shaabani, EC Vatansever, ...
bioRxiv, 2021.06. 08.447613, 2021
72021
The N-Terminal Carbamate is Key to High Cellular and Antiviral Potency for Boceprevir-Based SARS-CoV-2 Main Protease Inhibitors
YR Alugubelli, ZZ Geng, KS Yang, N Shaabani, K Khatua, XR Ma, ...
BioRxiv, 2021.12. 18.473330, 2021
52021
浅析氨基酸代谢在生物有机化学与化学生物学教学中的重要性
王志鹏, 马新雨, 颜惠娟, 田杰
大学化学 34 (1), 24-32, 2019
52019
The P3 O-Tert-Butyl-Threonine is Key to High Cellular and Antiviral Potency for Aldehyde-Based SARS-CoV-2 Main Protease Inhibitors
Y Ma, KS Yang, ZZ Geng, YR Alugubelli, N Shaabani, EC Vatansever, ...
bioRxiv, 2021.12. 18.473326, 2021
42021
A speedy route to multiple highly potent SARS-CoV-2 main protease inhibitors
KS Yang, XR Ma, Y Ma, YR Alugubelli, DA Scott, EC Vatansever, ...
bioRxiv, 2020.07. 28.223784, 2020
42020
将生物信息学与有机化学结合初探酶促反应原理与实践——介绍一个国外本科生实验并讨论其相关问题
田杰, 王志鹏, 马新雨, 蒋振雄, 许兵
大学化学 2, 2019
32019
从蛋白质糖基化的结构到功能: 以丝氨酸/苏氨酸 O-(N-乙酰) 葡糖胺修饰为例
田杰, 马新雨, 王志鹏
生命的化学 38 (5), 673-680, 2018
32018
Discovery of first-in-class PROTAC degraders of SARS-CoV-2 main protease
YR Alugubelli, J Xiao, K Khatua, S Kumar, L Sun, Y Ma, XR Ma, ...
Journal of Medicinal Chemistry, 2024
22024
An Azapeptide Platform in Conjunction with Covalent Warheads to Uncover High-Potency Inhibitors for SARS-CoV-2 Main Protease
K Khatua, YR Alugubelli, KS Yang, VR Vulupala, LR Blankenship, ...
bioRxiv, 2023.04. 11.536467, 2023
12023
酶促反应动力学教学刍议: 米氏方程衍生公式与图像
王志鹏, 车子良, 马新雨
化学教育 42 (8), 105-110, 2021
12021
以苯丙氨酸为例刍议芳香族氨基酸的生物合成机理
蒋振雄, 王志鹏, 马新雨, 颜惠娟, 缑允梓, 尹晟, 王鹏
化学教育 42 (2), 71-79, 2021
12021
刍议组蛋白去乙酰化酶的结构分类与功能调控
王志鹏, 张璇, 蒋振雄, 车子良, 马新雨
生命的化学 40 (12), 2151-2161, 2020
12020
The system can't perform the operation now. Try again later.
Articles 1–20